Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor

S Chaing, B Clarke, S Sridhara, K Chu, P Friedman, W VanDusen, HR Roberts, M Blajchman, DM Monroe, KA High

Blood (1994) 83 (12): 3524–3535.

https://doi.org/10.1182/blood.V83.12.3524.3524

Published: 1994

Journal Articles

Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B

JN Lozier, DM Monroe, S Stanfield-Oakley, SW Lin, KJ Smith, HR Roberts, KA High

Blood (1990) 75 (5): 1097–1104.

https://doi.org/10.1182/blood.V75.5.1097.1097

Published: 1990

Journal Articles

Molecular characterization of human factor XSan Antonio

SV Reddy, ZQ Zhou, KJ Rao, JP Scott, H Watzke, KA High, P Jagadeeswaran

Blood (1989) 74 (5): 1486–1490.

https://doi.org/10.1182/blood.V74.5.1486.1486

Published: 1989

Journal Articles

Molecular cloning of a cDNA encoding canine factor IX

JP Evans, HH Watzke, JL Ware, DW Stafford, KA High

Blood (1989) 74 (1): 207–212.

https://doi.org/10.1182/blood.V74.1.207.207

Published: 1989

Journal Articles

Functional consequences of an arginine180 to glutamine mutation in factor IX Hilo

DM Monroe, DM McCord, MN Huang, KA High, RL Lundblad, CK Kasper, HR Roberts

Blood (1989) 73 (6): 1540–1544.

https://doi.org/10.1182/blood.V73.6.1540.1540

Published: 1989

Journal Articles

Molecular defect in factor IXHilo, a hemophilia Bm variant: Arg----Gln at the carboxyterminal cleavage site of the activation peptide

MN Huang, CK Kasper, HR Roberts, DW Stafford, KA High

Blood (1989) 73 (3): 718–721.

https://doi.org/10.1182/blood.V73.3.718.718

Published: 1989

NARROW

Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor

Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B

Molecular characterization of human factor XSan Antonio

Molecular cloning of a cDNA encoding canine factor IX

Functional consequences of an arginine180 to glutamine mutation in factor IX Hilo

Molecular defect in factor IXHilo, a hemophilia Bm variant: Arg----Gln at the carboxyterminal cleavage site of the activation peptide

Email alerts

ASH Publications

American Society of Hematology

Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor

Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B

Molecular characterization of human factor XSan Antonio

Molecular cloning of a cDNA encoding canine factor IX

Functional consequences of an arginine180 to glutamine mutation in factor IX Hilo

Molecular defect in factor IXHilo, a hemophilia Bm variant: Arg----Gln at the carboxyterminal cleavage site of the activation peptide

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only